Case Control Study
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2014; 20(16): 4778-4786
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4778
Figure 1
Figure 1 Pathology of nonalcoholic steatohepatitis and control group liver after hematoxylin and eosin staining. A: Control group; B: Nonalcoholic steatohepatitis group.
Figure 2
Figure 2 Representative two-dimensional electrophoresis image of proteins from the control and nonalcoholic steatohepatitis rat livers. The numbered spots denote proteins that exhibited modified expression levels in nonalcoholic steatohepatitis (NASH) liver.
Figure 3
Figure 3 Significantly decreased hadha levels in nonalcoholic steatohepatitis rat mitochondria using Western blotting. NASH: Nonalcoholic steatohepatitis.
Figure 4
Figure 4 Peptide mass fingerprinting of an in-gel tryptic digest of the Hadha protein.